Dr. Manuel Muñoz-Torres specialized in Endocrinology and Nutrition in 1986 and received his Doctor of Medicine in 1987 from the University of Granada. He has led a translational Research Group integrated as IP in Cooperative Research Networks since 2007: Thematic Network for Cooperative Research Fragility and Aging (RETICEF) of the Carlos III Health Institute and the CIBER consortium of the thematic area of Frailty and Aging (CIBERFES). He has received continuous funding since 1998 for R & D & I projects financed in competitive calls from administrations or public and private entities (Carlos III Health Institute, Ministry of Science and Innovation, Health Council of the Junta de Andalucía, and Fundación Company-University of Granada, among others). He is a Coordinator of the Endocrine and Metabolic Diseases Area of the Biosanitary Research Institute of Granada (ibs.GRANADA). He has been a Professor of Medicine at the University of Granada since 2015. He is the director of twenty-seven doctoral theses, six final degree projects, and four final master's projects published in impact magazines. His priority lines of research are determining the mechanisms of bone fragility and vascular complications in patients with diabetes.
Research Keywords & Expertise
Nutrition
Obesity
Osteoporosis
Type 2 Diabetes
Vitamin D
Fingerprints
27%
Osteoporosis
16%
Type 2 Diabetes
10%
Vitamin D
8%
Obesity
6%
Nutrition
Short Biography
Dr. Manuel Muñoz-Torres specialized in Endocrinology and Nutrition in 1986 and received his Doctor of Medicine in 1987 from the University of Granada. He has led a translational Research Group integrated as IP in Cooperative Research Networks since 2007: Thematic Network for Cooperative Research Fragility and Aging (RETICEF) of the Carlos III Health Institute and the CIBER consortium of the thematic area of Frailty and Aging (CIBERFES). He has received continuous funding since 1998 for R & D & I projects financed in competitive calls from administrations or public and private entities (Carlos III Health Institute, Ministry of Science and Innovation, Health Council of the Junta de Andalucía, and Fundación Company-University of Granada, among others). He is a Coordinator of the Endocrine and Metabolic Diseases Area of the Biosanitary Research Institute of Granada (ibs.GRANADA). He has been a Professor of Medicine at the University of Granada since 2015. He is the director of twenty-seven doctoral theses, six final degree projects, and four final master's projects published in impact magazines. His priority lines of research are determining the mechanisms of bone fragility and vascular complications in patients with diabetes.